AngelisMWongLLMyersSAWongLM. Calciphylaxis in patients on hemodialysis: A prevalence study. Surgery1997;122:1083–9.
5.
WongJJLaumannAMartinezM. Calciphylaxis and antiphospholipid antibody syndrome. J Am Acad Dermatol2000;42:849.
6.
Riegert-JohnsonDLKaurJSPfeiferEA. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K. Mayo Clin Proc2001;76:749–52.
7.
RaperRFIbelsLS. Osteosclerotic myeloma complicated by diffuse arteritis, vascular calcification and extensive cutaneous necrosis. Nephron1985;39:389–92.
8.
OzbalkanZCalguneriMOnatAMOzturkMA. Development of calciphylaxis after long-term steroid and methotrexate use in a patient with rheumatoid arthritis. Intern Med2005;44:1178–81.
9.
NigwekarSUWolfMSternsRHHixJK. Calciphylaxis from nonuremic causes: A systematic review. Clin J Am Soc Nephrol2008;3:1139–43.
10.
MastruserioDNNguyenEQNielsenT. Calciphylaxis associated with metastatic breast carcinoma. J Am Acad Dermatol1999;41:295–8.
11.
KutluNOAydinNEAslanM. Malignant melanoma of the soft parts showing calciphylaxis. Pediatr Hematol Oncol2003;20:141–6.
12.
KorkmazCDundarEZubarogluI. Calciphylaxis in a patient with rheumatoid arthritis without renal failure and hyperparathyroidism: The possible role of long-term steroid use and protein S deficiency. Clin Rheumatol2002;21:66–9.
13.
GoffHWGrimwoodRE. A case of calciphylaxis and chronic myelomonocytic leukemia. Cutis2005;75:325–8.
14.
DeR IFiloticoRCeaM. Calciphylaxis in a patient with POEMS syndrome without renal failure and/or hyperparathyroidism. A case report. Ann Ital Med Int2004;19:283–7.
15.
CockerellCJDolanET. Widespread cutaneous and systemic calcification (calciphylaxis) in patients with the acquired immunodeficiency syndrome and renal disease. J Am Acad Dermatol1992;26:559–62.
16.
BoslerDSAminMBGulliFMalhotraRK. Unusual case of calciphylaxis associated with metastatic breast carcinoma. Am J Dermatopathol2007;29:400–3.
17.
BambergerNEmmerichJFiessingerJN. Calciphylaxis in patients with human immunodeficiency virus infection and renal disease. J Am Acad Dermatol1993;28:135–6.
18.
MunavalliGReisenauerAMosesM. Weight loss-induced calciphylaxis: Potential role of matrix metalloproteinases. J Dermatol2003;30:915–9.
19.
BarriYMGravesGSKnochelJP. Calciphylaxis in a patient with Crohn's disease in the absence of end-stage renal disease. Am J Kidney Dis1997;29:773–6.
20.
GoyalSHuhnKMProvostTT. Calciphylaxis in a patient without renal failure or elevated parathyroid hormone: Possible aetiological role of chemotherapy. Br J Dermatol2000;143:1087–90.
GoliAKGoliSAShahLS. Calciphylaxis: A rare association with alcoholic cirrhosis. Are deficiencies in protein C and S the cause?. South Med J2005;98:736–9.
23.
LimSPBattaKTanBB. Calciphylaxis in a patient with alcoholic liver disease in the absence of renal failure. Clin Exp Dermatol2003;28:34–6.
24.
AhmedSO'NeillKDHoodAF. Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis2001;37:1267–76.
25.
BleyerAJChoiMIgwemezieB. A case control study of proximal calciphylaxis. Am J Kidney Dis1998;32:376–83.
26.
MazharARJohnsonRJGillenD. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int2001;60:324–32.
27.
WeenigRHSewellLDDavisMD. Calciphylaxis: Natural history, risk factor analysis, and outcome. J Am Acad Dermatol2007;56:569–79.
28.
FineAZachariasJ. Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy. Kidney Int2002;61:2210–7.
29.
KriskovichMDHolmanJMHallerJR. Calciphylaxis: Is there a role for parathyroidectomy?Laryngoscope2000;110:603–7.
30.
GalimbertiRLFariasERParraIH. Cutaneous necrosis by calcific uremic arteriolopathy. Int J Dermatol2005;44:101–6.
31.
WeenigRH. Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol2008;58:458–71.
32.
WilmerWAMagroCM. Calciphylaxis: Emerging concepts in prevention, diagnosis, and treatment. Semin Dial2002;15:172–86.
33.
BleibelWHazarBHermanR. A case report comparing various radiological tests in the diagnosis of calcific uremic arteriolopathy. Am J Kidney Dis2006;48:659–61.
34.
LazorikFCFriedmanAKLeydenJJ. Xeroradiographic observations in four patients with chronic renal disease and cutaneous gangrene. Arch Dermatol1981;117:325–8.
35.
NorrisBVaysmanVLineBR. Bone scintigraphy of calciphylaxis: A syndrome of vascular calcification and skin necrosis. Clin Nucl Med2005;30:725–7.
36.
HaydenMRGoldsmithDSowersJRKhannaR. Calciphylaxis: Calcific uremic arteriolopathy and the emerging role of sodium thiosulfate. Int Urol Nephrol2008;40:443–51.
37.
MartinR. Mysterious calciphylaxis: Wounds with eschar—to debride or not to debride?Ostomy Wound Manage2004;50:64–70.
38.
HafnerJKeuschGWahlC. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): A complication of chronic renal failure and benefit from parathyroidectomy. J Am Acad Dermatol1995;33:954–62.
39.
HafnerJKeuschGWahlCBurgG. Calciphylaxis: A syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa1998;27:137–43.
40.
MilasMWeberCJ. Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism. Surgery2004;136:1252–60.
41.
BudisavljevicMNCheekDPlothDW. Calciphylaxis in chronic renal failure. J Am Soc Nephrol1996;7:978–82.
42.
GirottoJAHarmonJWRatnerLE. Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Surgery2001;130:645–50.
DuffyASchurrMWarnerTChenH. Long-term outcomes in patients with calciphylaxis from hyperparathyroidism. Ann Surg Oncol2006;13:96–102.
45.
CoutoFMChenHBlankRDDreznerMK. Calciphylaxis in the absence of end-stage renal disease. Endocr Pract2006;12:406–10.
46.
Arch-FerrerJEBeenkenSWRueLW. Therapy for calciphylaxis: An outcome analysis. Surgery2003;134:941–4.
47.
BasileCMontanaroAMasiM. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: A case series. J Nephrol2002;15:676–80.
48.
BasileC. Hyperbaric oxygen therapy in the treatment of calciphylaxis? Yes, more than hope. Kidney Int2002;62:2300.
49.
PodymowTWherrettCBurnsKD. Hyperbaric oxygen in the treatment of calciphylaxis: A case series. Nephrol Dial Transplant2001;16:2176–80.
50.
RaymondCBWaznyLD. Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. Am J Health Syst Pharm2008;65:1419–29.
51.
MonneyPNguyenQVPerroudHDescombesE. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant2004;19:2130–2.
52.
ShiraishiNKitamuraKMiyoshiT. Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium. Am J Kidney Dis2006;48:151–4.
HanafusaTYamaguchiYTaniM. Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates. J Am Acad Dermatol2007;57:1021–5.
55.
da CostaJBda CostaAGGomesMM. Pamidronate as a treatment option in calciphylaxis. J Eur Acad Dermatol Venereol2008;22:1128–30.
56.
RobinsonMRAugustineJJKormanNJ. Cinacalcet for the treatment of calciphylaxis. Arch Dermatol2007;143:152–4.
57.
SharmaABurkitt-WrightERustomR. Cinacalcet as an adjunct in the successful treatment of calciphylaxis. Br J Dermatol2006;155:1295–7.
58.
VelascoNMacGregorMSInnesAMacKayIG. Successful treatment of calciphylaxis with cinacalcet—an alternative to parathyroidectomy?Nephrol Dial Transplant2006;21:1999–2004.
59.
MohammedIASekarVBubtanaAJ. Proximal calciphylaxis treated with calcimimetic ‘cinacalcet.’Nephrol Dial Transplant2008;23:387–9.
60.
PallureVComteCLeray-MouraguesHDereureO. Cinacalcet as first-line treatment for calciphylaxis. Acta Derm Venereol2008;88:62–3.
61.
CiconeJSPetronisJBEmbertCDSpectorDA. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis2004;43:1104–8.
62.
GuerraGShahRCRossEA. Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: Case report. Nephrol Dial Transplant2005;20:1260–2.
63.
BrucculeriMCheighJBauerGSerurD. Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial2005;18:431–4.
64.
ArayaCEFennellRSNeibergerREDharnidharkaVR. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol2006;1:1161–6.
65.
HaydenMRTyagiSCKolbL. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: The emerging role of sodium thiosulfate. Cardiovasc Diabetol2005;4:4.
66.
MeissnerMBauerRBeierC. Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis. Dermatology2006;212:373–6.
67.
TokashikiKIshidaAKouchiM. Successful management of critical limb ischemia with intravenous sodium thiosulfate in a chronic hemodialysis patient. Clin Nephrol2006;66:140–3.
68.
BakerBLFitzgibbonsCABuescherLS. Calciphylaxis responding to sodium thiosulfate therapy. Arch Dermatol2007;143:269–70.
69.
AckermannFLevyADaugasE. Sodium thiosulfate as first-line treatment for calciphylaxis. Arch Dermatol2007;143:1336–7.
70.
SubramaniamKWallaceHSinniahRSakerB. Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate. Australas J Dermatol2008;49:30–4.
71.
MataicDBastaniB. Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis. Ren Fail2006;28:361–3.
72.
KadiyalaDRoerDAPerazellaMA. Nephrogenic systemic fibrosis associated with gadoversetamide exposure: Treatment with sodium thiosulfate. Am J Kidney Dis2009;53:133–7.
73.
YerramPSaabGKaruparthiPR. Nephrogenic systemic fibrosis: A mysterious disease in patients with renal failure—role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol2007;2:258–63.
74.
LinfertDRSchellJOFineDM. Treatment of nephrogenic systemic fibrosis: Limited options but hope for the future. Semin Dial2008;21:155–9.